Search

everythinglearnresearchcommunity

for

Search:↓

Combination drug therapy is effective for hirsutism that doesn't improve with just one medication.

The document suggests creating a validated score to diagnose Cushing's Syndrome and considers plasma steroid profiling as a simpler diagnostic method.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

Reproductive factors can increase hypertension risk and affect cardiovascular health.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Hair problems are common and distressing for women, but increasing knowledge of treatments offers hope.

The review found no clear link between vitamin D receptor gene variations and polycystic ovary syndrome.

Androgens like testosterone are important hormones for both men and women, made differently in each sex and affecting the body by regulating genes and quick interactions with cell components.

Women with PCOS are more likely to have fatty liver disease and worse metabolic health.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Manage hair shedding by identifying triggers, possibly using supplements or medications, and tracking with a health calendar.

Finasteride reduces hair growth and is safe for women with excessive hair.

Women with polycystic ovary syndrome tend to have a longer anogenital distance.

Antiandrogens can help treat skin conditions like acne and excessive hair in women when used carefully.

PRP treatment can safely boost hormone levels in some IVF patients with low ovarian reserve.

The research found different metabolism changes in PCOS patients and suggested new potential markers for diagnosing PCOS with or without insulin resistance.

Young women with high male hormone levels or PCOS often feel more psychological distress and have a lower quality of life.

The conclusion suggests a possible link between iron levels and hair health in women, recommending further research on iron supplementation for hair loss.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

Low prolactin in young women may increase heart and metabolism risks.

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.

Girls with PCOS during adolescence have a higher risk of developing type 2 diabetes, and early treatment can help manage this risk.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

The document concludes that it's important to understand the placebo effect when evaluating the effectiveness of treatments in medical trials.

Taking spironolactone and linestrenol for androgen excess can lead to lower bone density in young women.

Some growth factors, while important for normal body functions, can cause diseases when not regulated properly.

The study found that women with hyperandrogenic PCOS have higher levels of AKT1 and AKT2 proteins in their cells, which may lead to cell dysfunction.

Certain SHBG gene variants, like rs727428, are linked to higher testosterone levels in women with PCOS.

Most new moms had their hair grow back within 4-6 months after childbirth, and hair loss is likely due to hormonal changes.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.